CLB logo

Core Laboratories NV (CLB) Shareholders Equity

Annual Shareholders Equity

$224.81 M
+$40.56 M+22.01%

31 December 2023

CLB Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$250.74 M
+$10.47 M+4.36%

30 September 2024

CLB Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLB Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+22.0%+11.6%
3 y3 years+214.4%+60.2%
5 y5 years+43.4%+31.8%

CLB Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+214.4%at high+60.3%
5 y5 yearsat high+214.4%at high+303.8%
alltimeall time-22.3%+873.5%-13.4%+851.1%

Core Laboratories NV Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$250.74 M(+4.4%)
June 2024
-
$240.27 M(+3.5%)
Mar 2024
-
$232.16 M(+3.3%)
Dec 2023
$224.81 M(+22.0%)
$224.81 M(+0.1%)
Sept 2023
-
$224.69 M(+4.6%)
June 2023
-
$214.76 M(+9.9%)
Mar 2023
-
$195.39 M(+6.0%)
Dec 2022
$184.26 M(+17.8%)
$184.26 M(+3.2%)
Sept 2022
-
$178.54 M(+5.6%)
June 2022
-
$169.14 M(+4.5%)
Mar 2022
-
$161.78 M(+3.4%)
Dec 2021
$156.45 M(+118.8%)
$156.45 M(-0.1%)
Sept 2021
-
$156.56 M(+4.4%)
June 2021
-
$150.03 M(+5.7%)
Mar 2021
-
$141.88 M(+98.4%)
Dec 2020
$71.51 M(-59.8%)
$71.51 M(+5.7%)
Sept 2020
-
$67.63 M(+8.9%)
June 2020
-
$62.10 M(-5.5%)
Mar 2020
-
$65.72 M(-63.1%)
Dec 2019
$177.87 M(+13.5%)
$177.87 M(-6.5%)
Sept 2019
-
$190.25 M(+1.1%)
June 2019
-
$188.26 M(+2.8%)
Mar 2019
-
$183.16 M(+16.8%)
Dec 2018
$156.76 M(+8.2%)
$156.76 M(-0.4%)
Sept 2018
-
$157.44 M(+2.4%)
June 2018
-
$153.78 M(+4.2%)
Mar 2018
-
$147.64 M(+1.9%)
Dec 2017
$144.84 M(-4.3%)
$144.84 M(-3.0%)
Sept 2017
-
$149.37 M(+1.3%)
June 2017
-
$147.49 M(-1.3%)
Mar 2017
-
$149.41 M(-1.3%)
Dec 2016
$151.35 M(-620.8%)
$151.35 M(-4.0%)
Sept 2016
-
$157.59 M(-2.6%)
June 2016
-
$161.85 M(-584.8%)
Mar 2016
-
-$33.38 M(+14.9%)
Dec 2015
-$29.06 M(-133.2%)
-$29.06 M(+137.4%)
Sept 2015
-
-$12.24 M(-1192.2%)
June 2015
-
$1.12 M(-95.8%)
Mar 2015
-
$26.48 M(-69.8%)
Dec 2014
$87.57 M(-46.4%)
$87.57 M(-8.3%)
Sept 2014
-
$95.50 M(-26.6%)
June 2014
-
$130.16 M(-19.0%)
Mar 2014
-
$160.78 M(-1.6%)
Dec 2013
$163.32 M(-10.4%)
$163.32 M(-8.4%)
Sept 2013
-
$178.22 M(-1.7%)
June 2013
-
$181.31 M(-0.4%)
Mar 2013
-
$182.01 M(-0.1%)
Dec 2012
$182.23 M(+2.4%)
$182.23 M(-21.8%)
Sept 2012
-
$232.97 M(+5.7%)
June 2012
-
$220.39 M(+4.7%)
Mar 2012
-
$210.53 M(+18.3%)
Dec 2011
$177.90 M(-38.5%)
$177.90 M(+32.4%)
Sept 2011
-
$134.38 M(-46.0%)
June 2011
-
$249.06 M(-11.1%)
Mar 2011
-
$280.27 M(-3.2%)
Dec 2010
$289.49 M
$289.49 M(+18.1%)
Sept 2010
-
$245.19 M(+5.7%)
June 2010
-
$231.96 M(+3.4%)
DateAnnualQuarterly
Mar 2010
-
$224.24 M(-19.7%)
Dec 2009
$279.37 M(+50.1%)
$279.37 M(+12.7%)
Sept 2009
-
$247.82 M(+5.5%)
June 2009
-
$234.81 M(+13.6%)
Mar 2009
-
$206.73 M(+11.1%)
Dec 2008
$186.13 M(+199.5%)
$186.13 M(+48.7%)
Sept 2008
-
$125.21 M(+14.6%)
June 2008
-
$109.28 M(+46.5%)
Mar 2008
-
$74.58 M(+20.0%)
Dec 2007
$62.14 M(-13.5%)
$62.14 M(-9.2%)
Sept 2007
-
$68.46 M(-11.0%)
June 2007
-
$76.91 M(+37.8%)
Mar 2007
-
$55.83 M(-22.3%)
Dec 2006
$71.84 M(-66.5%)
$71.84 M(-62.3%)
Sept 2006
-
$190.44 M(-0.9%)
June 2006
-
$192.09 M(-7.6%)
Mar 2006
-
$207.84 M(-3.0%)
Dec 2005
$214.26 M(+12.6%)
$214.26 M(-0.5%)
Sept 2005
-
$215.23 M(+5.0%)
June 2005
-
$205.01 M(+5.0%)
Mar 2005
-
$195.27 M(+2.6%)
Dec 2004
$190.30 M(-13.7%)
$190.30 M(+2.0%)
Sept 2004
-
$186.56 M(-0.5%)
June 2004
-
$187.46 M(-8.9%)
Mar 2004
-
$205.89 M(-6.6%)
Dec 2003
$220.41 M(-14.6%)
$220.41 M(-1.7%)
Sept 2003
-
$224.34 M(-10.4%)
June 2003
-
$250.49 M(+0.0%)
Mar 2003
-
$250.45 M(-3.0%)
Dec 2002
$258.15 M(-6.3%)
$258.15 M(-4.9%)
Sept 2002
-
$271.44 M(+2.0%)
June 2002
-
$266.10 M(+1.5%)
Mar 2002
-
$262.13 M(-4.9%)
Dec 2001
$275.61 M(+9.8%)
$275.61 M(-0.8%)
Sept 2001
-
$277.87 M(+3.4%)
June 2001
-
$268.67 M(+3.7%)
Mar 2001
-
$259.01 M(+3.2%)
Dec 2000
$251.06 M(+18.3%)
$251.06 M(+3.2%)
Sept 2000
-
$243.38 M(+2.6%)
June 2000
-
$237.17 M(+11.1%)
Mar 2000
-
$213.51 M(+0.6%)
Dec 1999
$212.32 M(+6.6%)
$212.32 M(+4.4%)
Sept 1999
-
$203.30 M(+4.4%)
June 1999
-
$194.70 M(+1.5%)
Mar 1999
-
$191.80 M(-3.7%)
Dec 1998
$199.10 M(+75.3%)
$199.10 M(+5.3%)
Sept 1998
-
$189.00 M(+11.6%)
June 1998
-
$169.30 M(+42.7%)
Mar 1998
-
$118.60 M(+4.4%)
Dec 1997
$113.60 M(+139.7%)
$113.60 M(+98.9%)
Sept 1997
-
$57.10 M(+8.6%)
June 1997
-
$52.60 M(+6.7%)
Mar 1997
-
$49.30 M(+4.0%)
Dec 1996
$47.40 M(+27.8%)
$47.40 M(+10.7%)
Sept 1996
-
$42.80 M(+5.4%)
June 1996
-
$40.60 M(+4.9%)
Mar 1996
-
$38.70 M(+4.3%)
Dec 1995
$37.10 M
$37.10 M(+5.1%)
Sept 1995
-
$35.30 M

FAQ

  • What is Core Laboratories NV annual stockholders equity?
  • What is the all time high annual shareholders equity for Core Laboratories NV?
  • What is Core Laboratories NV annual shareholders equity year-on-year change?
  • What is Core Laboratories NV quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Core Laboratories NV?
  • What is Core Laboratories NV quarterly shareholders equity year-on-year change?

What is Core Laboratories NV annual stockholders equity?

The current annual shareholders equity of CLB is $224.81 M

What is the all time high annual shareholders equity for Core Laboratories NV?

Core Laboratories NV all-time high annual stockholders equity is $289.49 M

What is Core Laboratories NV annual shareholders equity year-on-year change?

Over the past year, CLB annual stockholders equity has changed by +$40.56 M (+22.01%)

What is Core Laboratories NV quarterly stockholders equity?

The current quarterly shareholders equity of CLB is $250.74 M

What is the all time high quarterly shareholders equity for Core Laboratories NV?

Core Laboratories NV all-time high quarterly stockholders equity is $289.49 M

What is Core Laboratories NV quarterly shareholders equity year-on-year change?

Over the past year, CLB quarterly stockholders equity has changed by +$26.05 M (+11.59%)